Enhanced Chondrogenic Capacity of Mesenchymal Stem Cells After TNFα Pre-treatment

Mesenchymal stem cells (MSCs) are promising cells to treat cartilage defects due to their chondrogenic differentiation potential. However, an inflammatory environment during differentiation, such as the presence of the cytokine TNFα, inhibits chondrogenesis and limits the clinical use of MSCs. On th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Bioeng Biotechnol
Asıl Yazarlar: Voskamp, Chantal, Koevoet, Wendy J. L. M., Somoza, Rodrigo A., Caplan, Arnold I., Lefebvre, Véronique, van Osch, Gerjo J. V. M., Narcisi, Roberto
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Bioengineering and Biotechnology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7344141/
https://ncbi.nlm.nih.gov/pubmed/32714905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00658
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller